Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alveolar Bone Regeneration with Human Mesenchymal Stem Cell Conditioned Medium
jRCT1051240285Recruiting
- Sponsor
- Yoshino Toshiaki
- Start
- Mar 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in gingival disease and Alveolar bone atrophy (ABL), sponsored by Yoshino Toshiaki. Primary endpoint: Alveolar bone regeneration on CT imaging. Started Mar 2025; status: recruiting.
02
Conditions
gingival diseaseAlveolar bone atrophy (ABL)
Beyond the preview
Go deeper on jRCT1051240285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240285.